| Cat.No. |
Chemical Name |
Formula Weight |
| N0084 |
1094250-15-3 | Englerin A |
442.56 |
| N0081 |
118-34-3 | Eleutheroside B |
372.36 |
| N0069 |
15674-58-5 | Delphinidin 3-rutinoside chloride |
365.42 |
| N0064 |
1182-34-9 | Cynarin |
516.45 |
| N0061 |
18719-76-1 | Cyanidin 3-rutinoside chloride |
630.98 |
| N0060 |
171828-62-9 | Cyanidin 3-(6”-malonylglucoside) |
|
| N0047 |
18942-26-2 | Chebulinic acid |
956.68 |
| N0044 |
154-23-4 | (+)-Catechin |
290.27 |
| N0043 |
18829-70-4 | (-)-Catechin |
308.28 |
| N0040 |
19086-75-0 | Castalin |
|
| N0029 |
11141-17-6 | Azadirachtin |
720.72 |
| N0027 |
17413-38-6 | Aristolochic acid D |
357.27 |
| N0023 |
10190-99-5 | Aristolochic acid Sodium salt ,mixture of Aristolochic acids I und II as
main components, Sodium salt |
363.25 |
| N0018 |
1617-53-4 | Amentoflavone |
538.46 |
| N0014 |
11027-63-7 | Agnuside |
466.44 |
| N0012 |
18642-44-9 | Actein |
676.83 |
| N0006 |
122651-20-1 | 3-O-Acetyl-9-11-dehydro-β-boswellic acid |
496.71 |
| PS1010 |
181695-72-7 | Valdecoxib |
314.359 |
| PS1009 |
198470-85-8 | Parecoxib Sodium |
392.405 |
| PS1008 |
198470-82-5 | N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide |
384.45 |
| PS1007 |
198471-06-6 | Parecoxib Impurity 10 |
356.40 |
| PS1006 |
1373038-59-5 | Valdecoxib Impurity I |
393.44 |
| PS1005 |
1373038-60-8 | Valdecoxib Impurity B |
611.69 |
| PS1004 |
1708094-99-8 | Parecoxib Sodium impurity Y |
505.56 |
| PS1002 |
181696-35-5 | Valdecoxib Impurity D |
315.34 |
| PS1000 |
181696-73-1 | Parecoxib Sodium Impurity U |
253.30 |
| NH1000 |
16676-29-2 | Naltrexone hydrochloride |
377.86 |
| 110021 |
100043-01-4 | zinc(II) 2,9,16,23-(tetra-nitro)phthalocyanine |
757.89 |
| 230056 |
1315-03-3 | Vanadium sulfide |
198.08 |
| BB10831 |
14458-05-0 | 2,3,5,6-tetramethylterephthalicacid |
222.24 |
